Regulatory

Regulatory  ·  Weekly Digest 21 to 27 Sep 2024
Innate Pharma Announces FDA Clearance of the IND for IPH4502, a Nectin-4 ADC to Be Developed in Solid Tumors

Weekly Digest – September 2024 Weekly Digest – September 2024 23 Sep 2024: Innate Pharma Announces FDA Clearance of the IND for IPH4502, a Nectin-4 ADC to Be Developed in Solid Tumors Innate Pharma has received FDA clearance for its […]

by Sandhya Ramalingam

Continue Reading
Regulatory  ·  Weekly Digest 21 to 27 Sep 2024
FDA Grants Fast Track Status to EO-3021 for CLDN18.2-Expressing Gastric or GEJ Cancer

Weekly Digest – September 2024 Weekly Digest – September 2024 24 Sep 2024: FDA Grants Fast Track Status to EO-3021 for CLDN18.2-Expressing Gastric or GEJ Cancer EO-3021 (SYSA1801) has received fast track designation for advanced or metastatic CLDN18.2-expressing gastric or […]

by Sandhya Ramalingam

Continue Reading